IRIS
IERARDI, ENZO GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.430
EU - Europa 4.715
AS - Asia 3.248
SA - Sud America 362
Continente sconosciuto - Info sul continente non disponibili 65
AF - Africa 32
OC - Oceania 8
Totale 15.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.357
CN - Cina 1.502
IE - Irlanda 1.306
UA - Ucraina 1.036
SG - Singapore 894
SE - Svezia 726
RU - Federazione Russa 619
BR - Brasile 301
HK - Hong Kong 298
IT - Italia 285
FR - Francia 267
TR - Turchia 220
IN - India 185
FI - Finlandia 180
GB - Regno Unito 141
DE - Germania 78
VN - Vietnam 58
CA - Canada 36
AR - Argentina 27
IQ - Iraq 19
MX - Messico 16
ES - Italia 15
EU - Europa 13
PL - Polonia 13
ZA - Sudafrica 13
NL - Olanda 12
BD - Bangladesh 9
EC - Ecuador 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
PK - Pakistan 7
MA - Marocco 6
AZ - Azerbaigian 5
BE - Belgio 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
JP - Giappone 5
AT - Austria 4
AU - Australia 4
CO - Colombia 4
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PE - Perù 4
TN - Tunisia 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
ID - Indonesia 3
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
GE - Georgia 2
JO - Giordania 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
RO - Romania 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MU - Mauritius 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.810
Salva come PNG Salva come JPEG
Città #
Dublin 1.302
San Jose 1.077
Chandler 917
Jacksonville 735
Dearborn 580
Ashburn 445
Singapore 381
Nanjing 376
Nyköping 374
Hong Kong 296
Wilmington 221
Beijing 191
Santa Clara 165
Council Bluffs 164
Princeton 149
San Mateo 144
Lauterbourg 123
Columbus 118
Nanchang 115
Boardman 114
Woodbridge 85
Dallas 74
Kunming 74
Hebei 69
Shenyang 69
Moscow 67
Ann Arbor 63
Los Angeles 63
Tianjin 59
Des Moines 58
Jiaxing 54
Changsha 50
Buffalo 46
Fresno 46
Guangzhou 44
Seattle 43
New York 40
Shanghai 37
Hilden 34
Helsinki 33
Hangzhou 32
The Dalles 32
Jinan 30
Stevenage 28
São Paulo 24
Ho Chi Minh City 19
Pune 19
Rome 19
Phoenix 18
Changchun 17
Ningbo 15
Brooklyn 14
Rio de Janeiro 14
Taizhou 14
Orem 13
Boston 12
Dong Ket 12
Norwalk 12
Philadelphia 12
Shenzhen 12
Auburn Hills 11
Milan 11
Zhengzhou 11
Frankfurt am Main 10
Hanoi 10
Lanzhou 10
London 10
Salt Lake City 10
Haddonfield 9
Warsaw 9
Wuhan 9
Atlanta 8
Chennai 8
Chicago 8
Nuremberg 8
Wuxi 8
Amsterdam 7
Baghdad 7
Belo Horizonte 7
Hefei 7
Quanzhou 7
Bari 6
Florence 6
Hanover 6
Johannesburg 6
San Francisco 6
Abbeville 5
Alexandria 5
Baku 5
Bologna 5
Brasília 5
Brussels 5
Fuzhou 5
Montreal 5
Napoli 5
Porto Alegre 5
Quito 5
Saint Petersburg 5
Tokyo 5
Toronto 5
Totale 9.748
Salva come PNG Salva come JPEG
Nome #
LA COLITE SEGMENTARIA ASSOCIATA AI DIVERTICOLI: USO DEL DEL bECLOMETASONE dipropionatoNELLE FORME EMORRAGICHE 328
Helicobacter Heilmannii: un nuovo batterio dello stomaco. Come si ricerca e suo ruolo nella pratica clinica 170
"Clarithromycin-resistant genotypes and eradication of Helicobacter pylori." 154
A case of adverse reaction potentially related to a microbubble contrast agent for ultrasonography. 153
Argon plasma coagulation in the treatment of haemorragic solitary ulcer syndrome. 147
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. 146
Argon plasma coagulation of haemorragic solitary rectal ulcer syndrome. 138
57. M Barone, E Maiorano, R Ladisa, A Pece, P Berloco, M Strazzabosco, ML Caruso, AM Valentini, E Ierardi, A Di Leo, A Francavilla. Ursodeoxycholate further increases bile duct cell proliferative response induced by partial bile duct ligation in rats. 137
H. pylori antibiotic resistance and 13C urea breath test values. J Med Microbiol. 2010 Jan 21. 136
H. pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years 134
Peritoneo-venous shunting for ascites: a five year experience with LeVeen and Denver shunts. 134
Modulation of rat Hepatocyte proliferation by bile salts: in vitro and in vivo studies 133
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. 133
Autoantibodies reacting with gastric antigens in Helicobacter pylori gastritis of dyspeptic children 132
Binding of Campylobacter pylori to human peripheral blood lymphocytes 130
"Nutrizione in Gastroenterologia" 130
Circadian rhythm of hepatic estrogen receptors 130
Helicobacter pylori and chronic antral erosions: our experience. 129
Liver damage onset after a single infliximab administration in a patient with refractory ulcerative colitis 127
An inter and intra-laboratory comparison of breath 13CO2 . 127
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. 127
Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report 127
Pseudotumoural lesion of the abdominal wall due to a fishbone migration 127
I nucleotidi ciclici (cAMP e cGMP) nell' ascite come markers di recidiva da carcinoma ovarico. 127
The augmenter of liver regeneration induces mithochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mithochondria. 126
"Alterazioni dello stato nutrizionale" 126
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori: a multicenter study. 125
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicenter study. 125
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses. 123
I breath tests nell’ insufficienza panctreatica, nelle malattie epatiche e nell’ alitosi. 123
Circadian rhythm of hepatic estrogen receptors. 122
Malattia da reflusso gastro-esofageo e dispepsia non ulcerosa. 122
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV seronegative pregnant women: a 24 month prospective study. 121
A life threatning event following the injection of a microbubble contrast agent for ultrasonography. 121
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost-effectiveness 120
Incidence and risk factors of duodenal ulcer 119
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori 119
A new semiquantitative method of quantifying Helicobacter pylori antigen in stools 119
Cyclic nucleotides in ascites from ovarian carcinoma 119
There is a role for sequential in sequential anti-H. pylori therapy? (Reply of the authors). 116
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrintestinal symptoms 115
Campylobacter fetus bacteriemia in an immunocompromised patient: a case report and review of literature. 115
The pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated to diverticula suggests a truly autonomous clinical entity. 115
Epidemiology of gastroesophageal reflux 115
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. 115
Anisakis pegreffi etiological agent of gastric infections in two Italian women. 114
Reflux symptoms in professional opera choristers. 114
Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. 114
Improved Efficacy of 10 Day Sequential Treatment For Helicobacter Pylori Eradication In Children: A Randomised Trial. 113
Immunohistochemical detection of Helicobacter Pylori vacuolating cytoxin in the hepatocytes of patients with isolated hypertransaminasemia 113
A oral Tacrolimus long-term therapy in parients with Crohn’s disease and steroid resistance 113
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits 113
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 112
Malnutrizione in Gastroenterologia. 112
Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection. 112
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. 112
A third-line levofoxacin-based rescue therapy for Helicobacter pylori eradication. 111
Estrogens, androgens and EGF receptor expression in gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine. 111
Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 111
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. 111
Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation 111
Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis 109
Immunohistostaining of hepatitis C virus (HCV) non-structural protein 4 (NS 4) in ependymocytes of uninfected mice: an antigenic mimicry? 109
Two new treatment regimens for Helicobacter pilori eradication: a randomised study 109
Tumor necrosis alpha serum levels parallels isolated hypertransaminasemia in the third trimester of pregnancy 109
Update on Helicobacter pylori research. Malignancies. 108
Effect of Lactobacillus reuteri on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy in children: a randomised clinical trial 108
“Mycophenolate mofetil in the treatment of autoimmune hcv-associated haematological disorders showing steroid resistance or dependence.” J Viral Hepat 108
High eradication rates for Helicobacter pylori with a new sequential treatment. 107
Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice 107
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. 107
Claritromycin resistance and Helicobacter pylori genotypes in Italy. 107
Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? 107
ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis. 106
Role of different clarithromycin resistance genotypes on Helicobacter pylori eradication. 106
Effect of eradicating therapy on cell proliferation in Helicobacter pylori-related lesions 106
Gastrospirillum hominis and human chronic gastritis 104
Celiac plexus under endoscopy ultrasonographic guidance complication. 104
Tumour necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 104
Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis. 103
Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. 103
Ruolo attuale e progressi tecnologici dell’ecografia transaddominale nell’ imaging delle vie biliari 103
Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. 102
TUMOUR NECROSIS FACTOR ALPHA DOWNREGULATION AND BASIC FIBROBLAST GROWTH FACTOR/SYNDECAN 1 LINK: A POSSIBLE MOLECULAR PATHWAY OF MUCOSAL HEALING IN ULCERATIVE COLITIS 102
Life threatening adverse event after injection of microbubble contrast agent for abdominal ultrasonography: first report. 102
The prolongation of triple therapy for Helicobacter pylori does not allows reaching therapeutic outcome of sequential scheme: a prospective, randomized study. 102
Gastro-esophageal reflux disease and lactose malabsorption: casual comorbidity or neglected association? 102
Lupus nephritis improvement after anti-tumour necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn’s disease: a case report. 102
Worldwide H. pylori antibiotic resistance: a systematic review. 102
Helicobacter Heilmannii gastritis: a histological and immunohistochemical trait 101
Helicobacter species in liver and biliary diseases. 101
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. 100
“Probiotic Multistrain Treatment May Eradicate Helicobacter pylori from the Stomach of Dyspeptics: A Placebo-Controlled Pilot Study.” Inflamm Allergy Drug Targets. 2012 Jun 1;11(3):244-9 100
Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. 99
Endoultrasonographic guided alcohol lavage of a pancreatic fluid collection: a case report 99
Effects of ranitidine: a short-term clinical trial for duodenal ulcer treatment using two different types of oral administration. Serum prolactin stimulation after bolus injection. 99
Small intestinal contrast ultrasonograpy based scoring system: a promising approach for the diagnosis and follow-up of celiac disease. 99
Tumor necrosis factor alpha in segmental colitis associated with diverticula. 99
Pathways and gene expression profiles in hepatocellular carcinoma 99
Pattern of apoptosis in Crohn’ s disease: a singular aspect. 98
Totale 11.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 0 0 10 62 30 35 66 94 69 41 174
2022/20233.441 250 125 114 272 279 387 23 240 1.550 22 84 95
2023/2024454 111 26 22 15 57 149 1 28 0 5 0 40
2024/20251.811 94 39 98 90 94 310 146 142 483 55 131 129
2025/20263.065 184 123 271 396 106 162 891 365 164 218 48 137
2026/2027863 52 314 253 244 0 0 0 0 0 0 0 0
Totale 15.860